Last reviewed · How we verify
NCT05606575
A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning - Nelli
trial testing Nelli in Epilepsy in 150 participants. Completed in 31 January 2026.
31 December 2025
Quick facts
| Lead sponsor | Neuro Event Labs Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 1 August 2022 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 January 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Nelli
Conditions studied
- Epilepsy — all drugs for Epilepsy →
Sponsor
Neuro Event Labs Inc.
Who can join
Adults 6 to 21, any sex, with Epilepsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Nelli is a video-based non-EEG physiological seizure monitoring system. This study is a blinded comparison of Nelli's identified events to gold-standard video EEG review in at-rest pediatric subjects with suspected motor seizures.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05606575
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Nelli
Trials testing the same drug.
- NCT06705439 — A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning (USF) · completed
- NCT04738552 — A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning · completed
Other recruiting trials for Epilepsy
Currently open trials in the same condition.
- NCT07095933 — The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy · EARLY_PHASE1 · recruiting
- NCT07224191 — Hippocampal Oscillations During Exploration · NA · recruiting
- NCT07219407 — A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures · Phase 2 · recruiting
- NCT07417280 — LIFUS For Neurological Disorders · NA · recruiting
- NCT07490769 — Levetiracetam Three Times Daily in Epilepsy · Phase 3 · recruiting
Other Neuro Event Labs Inc. trials
Trials by the same sponsor.
- NCT06705439 — A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning (USF) · completed
- NCT04738552 — A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05606575 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Neuro Event Labs Inc.
- Last refreshed: 13 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05606575.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing